Return to content in this issue

 

Successful Subcutaneous Desensitization to Certolizumab Pegol

Peñalver MJ, Bautista-Villanueva S, Barranco R, Crespo JF, Mielgo R

Allergy Department, Hospital Universitario 12 de Octubre, Madrid, Spain

J Investig Allergol Clin Immunol 2024; Vol 34(4) : 272-274
doi: 10.18176/jiaci.0981

Key words: TNFα inhibitor, Certolizumab, Hypersensitivity, Desensitization, Allergy